Malignant pleural mesothelioma: an epidemiological perspective

被引:217
|
作者
Robinson, Benjamin M. [1 ]
机构
[1] Baird Inst Appl Heart & Lung Surg Res, Sydney, NSW, Australia
关键词
Asbestos; epidemiology; incidence; malignant mesothelioma;
D O I
10.3978/j.issn.2225-319X.2012.11.04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This paper reviews the aetiology, distribution and projected future incidence of malignant mesothelioma. Asbestos exposure is the most thoroughly established risk factor. Debate continues regarding the relative importance of the different asbestos fibre types and the contribution of Simian virus 40 (SV40). Disease incidence varies markedly within and between countries. The highest annual rates of disease, approximately 30 case per million, are reported in Australia and Great Britain. The risk of disease increases with age and is higher in men. Time from asbestos exposure to disease diagnosis is on average greater than 40 years. Nonoccupational asbestos exposures contribute an increasing proportion of disease. With the exception of the United States, incidence continues to increase. In developed countries peak incidence is expected to occur before 2030.
引用
收藏
页码:491 / 496
页数:6
相关论文
共 50 条
  • [21] Malignant pleural mesothelioma: Diagnosis and treatment
    Delourme, J.
    Dhalluin, X.
    Cortot, A. B.
    Lafitte, J. -J.
    Scherpereel, A.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2013, 69 (01) : 26 - 35
  • [22] KRAS signaling in malignant pleural mesothelioma
    Marazioti, Antonia
    Krontira, Anthi C.
    Behrend, Sabine J.
    Giotopoulou, Georgia A.
    Ntaliarda, Giannoula
    Blanquart, Christophe
    Bayram, Hasan
    Iliopoulou, Marianthi
    Vreka, Malamati
    Trassl, Lilith
    Pepe, Mario A. A.
    Hackl, Caroline M.
    Klotz, Laura, V
    Weiss, Stefanie A., I
    Koch, Ina
    Lindner, Michael
    Hatz, Rudolph A.
    Behr, Juergen
    Wagner, Darcy E.
    Papadaki, Helen
    Antimisiaris, Sophia G.
    Jean, Didier
    Deshayes, Sophie
    Gregoire, Marc
    Kayalar, Ozgecan
    Mortazavi, Deniz
    Dilege, Sukru
    Tanju, Serhan
    Erus, Suat
    Yavuz, Omer
    Bulutay, Pinar
    Firat, Pinar
    Psallidas, Ioannis
    Spella, Magda
    Giopanou, Ioanna
    Lilis, Ioannis
    Lamort, Anne-Sophie
    Stathopoulos, Georgios T.
    EMBO MOLECULAR MEDICINE, 2022, 14 (02)
  • [23] Prognostic factors in malignant pleural mesothelioma
    Davidson, Ben
    HUMAN PATHOLOGY, 2015, 46 (06) : 789 - 804
  • [24] Environmental cancer: malignant pleural mesothelioma
    Margery, Jacques
    Ruffie, Pierre
    BULLETIN DU CANCER, 2008, 95 (01) : 77 - 86
  • [25] Malignant pleural mesothelioma metastasis to the mandible
    Terakodo, N
    Shintani, S
    Nakashiro, K
    Hamakawa, H
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 33 (08) : 798 - 800
  • [26] Surgical Management of Malignant Pleural Mesothelioma
    Yanagawa, Jane
    Rusch, Valerie
    THORACIC SURGERY CLINICS, 2013, 23 (01) : 73 - +
  • [27] Malignant Pleural Mesothelioma: A Comprehensive Review
    Jain, Molly
    Crites, Morgan Kay
    Rich, Patricia
    Bajantri, Bharat
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
  • [28] Psammoma bodies in malignant pleural mesothelioma
    Miyoshi, Isao
    Komatsu, Naoki
    Daibata, Masanori
    Kobayashi, Makoto
    Hiroi, Makoto
    Ohtsuki, Yuji
    Taguchi, Hirokuni
    INTERNAL MEDICINE, 2007, 46 (08) : 529 - 530
  • [29] Malignant pleural mesothelioma: recent developments
    Sinn, Katharina
    Mosleh, Berta
    Hoda, M. Alireza
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (01) : 80 - 86
  • [30] Brain metastases in malignant pleural mesothelioma
    Tomoko Yamagishi
    Nobukazu Fujimoto
    Yosuke Miyamoto
    Michiko Asano
    Yasuko Fuchimoto
    Sae Wada
    Kenichi Kitamura
    Shinji Ozaki
    Hideyuki Nishi
    Takumi Kishimoto
    Clinical & Experimental Metastasis, 2016, 33 : 231 - 237